Omid C. Farokhzad, Founder, CEO & Chair of the Board, stated Q2 2025 was a pivotal quarter with "discipline, advance key commercial and product milestones and accelerate the validation and impact of ...
10don MSN
Seer expects 2025 revenue at lower end of $17M–$18M range amid persistent funding headwinds
Q3 2025 Management View CEO Omid Farokhzad emphasized the company's continued momentum, highlighting "a record number of ...
REDWOOD CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the ...
Seer, Inc. ( (SEER)) has released its Q3 earnings. Here is a breakdown of the information Seer, Inc. presented to its investors. Seer, Inc. is a life sciences company pioneering a new proteomics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback